Uncategorized
Avedro begins two new cross-linking trials in US
Avedro announced that the first patients have been treated in two U.S. Food and Drug Administration clinical trials, according to a press release. LASIK with cross-linking (LASIK Xtra) is a 2-minute procedure to investigate if cross-linking after LASIK reduces regression of refractive outcome in patients with hyperopia or hyperopic astigmatism, the release said.